Merit Medical Systems (FRA:MM3) Cyclically Adjusted Revenue per Share: €19.40 (As of Mar. 2026)


FRA:MM3 Merit Medical Systems Inc FRA:MM3
87 GF Score
Price €64.00
GF Value €84.09
Valuation Modestly Undervalued
View Full Analysis

What is Merit Medical Systems Cyclically Adjusted Revenue per Share?

Merit Medical Systems FRA:MM3 +4.07% 87 Cyclically Adjusted Revenue per Share is €19.40 as of Mar. 2026. GuruFocus rates FRA:MM3 with a GF Score™ of 87/100 and a GF Value™ of €84.09 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Merit Medical Systems's adjusted revenue per share for the three months ended in Mar. 2026 was €5.504. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €19.40 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merit Medical Systems's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Merit Medical Systems was 18.40% per year. The lowest was 7.10% per year. And the median was 9.60% per year.

As of today (2026-07-12), Merit Medical Systems's current stock price is €64.00. Merit Medical Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €19.40. Merit Medical Systems's Cyclically Adjusted PS Ratio of today is 3.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merit Medical Systems was 5.46. The lowest was 1.86. And the median was 3.96.


Merit Medical Systems  (FRA:MM3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Merit Medical Systems's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=64.00/19.40
=3.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merit Medical Systems was 5.46. The lowest was 1.86. And the median was 3.96.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Merit Medical Systems Cyclically Adjusted Revenue per Share Related Terms


Merit Medical Systems Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems Cyclically Adjusted Revenue per Share Chart

Merit Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.20 16.37 17.16 19.45 18.34

Merit Medical Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.28 17.88 18.36 18.34 19.40

FRA:MM3 vs NVST, MMED, ICUI: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merit Medical Systems Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Merit Medical Systems's Cyclically Adjusted PS Ratio falls into.


FRA:MM3
87GF Score
Merit Medical Systems Inc FRA:MM3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merit Medical Systems's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.504/330.2130*330.2130
=5.504

Current CPI (Mar. 2026) = 330.2130.

Merit Medical Systems Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.008 241.018 4.121
201609 3.108 241.428 4.251
201612 3.311 241.432 4.529
201703 3.491 243.801 4.728
201706 3.244 244.955 4.373
201709 2.916 246.819 3.901
201712 3.118 246.524 4.176
201803 3.172 249.554 4.197
201806 3.690 251.989 4.835
201809 3.447 252.439 4.509
201812 3.633 251.233 4.775
201903 3.734 254.202 4.851
201906 3.999 256.143 5.155
201909 4.001 256.759 5.146
201912 4.163 256.974 5.349
202003 3.989 258.115 5.103
202006 3.500 257.797 4.483
202009 3.732 260.280 4.735
202012 3.816 260.474 4.838
202103 3.670 264.877 4.575
202106 4.062 271.696 4.937
202109 3.944 274.310 4.748
202112 4.278 278.802 5.067
202203 4.347 287.504 4.993
202206 4.845 296.311 5.399
202209 5.037 296.808 5.604
202212 4.778 296.797 5.316
202303 4.777 301.836 5.226
202306 5.052 305.109 5.468
202309 5.060 307.789 5.429
202312 5.097 306.746 5.487
202403 5.082 312.332 5.373
202406 5.346 314.175 5.619
202409 5.143 315.301 5.386
202412 5.595 315.605 5.854
202503 5.364 319.799 5.539
202506 5.471 322.561 5.601
202509 5.462 324.800 5.553
202512 5.604 324.054 5.711
202603 5.504 330.213 5.504

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €19.40 mean?
Merit Medical Systems (FRA:MM3) has a Cyclically Adjusted Revenue per Share of €19.40 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Merit Medical Systems and its competitors.
Is Merit Medical Systems' Cyclically Adjusted Revenue per Share too high?
Merit Medical Systems' current Cyclically Adjusted Revenue per Share is €19.40. Overall, Merit Medical Systems has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Cyclically Adjusted Revenue per Share compare to NVST and MMED?
Merit Medical Systems' Cyclically Adjusted Revenue per Share of €19.40 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Merit Medical Systems and its competitors. Merit Medical Systems's current Cyclically Adjusted Revenue per Share is €19.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €84.09, compared to a current price of €64.00 — trading 23.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €19.40. Merit Medical Systems' overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Cyclically Adjusted Revenue per Share is €19.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of €64.00 is trading 23.9% below its estimated GF Value™ of €84.09. GuruFocus considers Merit Medical Systems to be Modestly Undervalued.

Key valuation signals for FRA:MM3:

  • Cyclically Adjusted Revenue per Share: €19.40
  • GF Value™: €84.09 vs. price of €64.00 (23.9% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merit Medical Systems Business Description

Other Exchanges MMSI:USA
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
87GF Score

Get the complete analysis for FRA:MM3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.00
Price
€84.09
GF Value